These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 2981407)
1. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407 [TBL] [Abstract][Full Text] [Related]
2. [Prevalence of antibodies against HTLV-III in various regions in Switzerland]. Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208 [TBL] [Abstract][Full Text] [Related]
4. Epidemiological survey of HIV infection in the Veneto region of Italy. Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208 [TBL] [Abstract][Full Text] [Related]
5. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592 [TBL] [Abstract][Full Text] [Related]
6. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106 [TBL] [Abstract][Full Text] [Related]
7. Screening for AIDS. Med Lett Drugs Ther; 1985 Mar; 27(684):29-30. PubMed ID: 2984526 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy]. Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134 [TBL] [Abstract][Full Text] [Related]
9. [Detection of HTLV-III antibodies using ELISA and the western blot]. Kunz C; Heinz FX Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany. Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
12. [HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS]. Hengster P; Blecha HG; Deinhardt F; Erfle V; Fuchs D; Goebel FD; Gürtler LG; Hausen A; Hinterhuber H; Reibnegger G Dtsch Med Wochenschr; 1986 Mar; 111(12):453-7. PubMed ID: 3004878 [TBL] [Abstract][Full Text] [Related]
13. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis. Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497 [TBL] [Abstract][Full Text] [Related]
14. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822 [TBL] [Abstract][Full Text] [Related]
15. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640 [TBL] [Abstract][Full Text] [Related]
17. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany. Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593 [TBL] [Abstract][Full Text] [Related]
18. [Acquired immunodeficiency syndrome (AIDS). An update after 4 years]. Vogt M; Lüthy R; Siegenthaler W Schweiz Med Wochenschr; 1985 May; 115(19):665-71. PubMed ID: 2988117 [TBL] [Abstract][Full Text] [Related]
19. HTLV-III AIDS link. Bennett JA Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353 [TBL] [Abstract][Full Text] [Related]